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Conclusions: Results confirm previous studies showing large 
variation in duodenum volume between fractions in a given 
patient. For patients where the duodenum and PTV overlap, 
evaluation of volume receiving dose around 30-55Gy presents 
the largest error due to interfraction differences. This study 
suggests that a reduction in dose volume metrics of the 
duodenum is likely to be due to an increase in the percentage 
of the duodenum located outside the PTV. However, this 
parameter still suffers from interfraction effects. 
These finding suggest that toxicity predictions based on 
either duodenum volume, percentage of duodenum outside 
PTV or the DSH from the planning CT alone may be 
inaccurate. Further work needs to be undertaken in order to 
better estimate toxicity. 
   
EP-1475   
Computational modelling of the microvasculature: effects 
of microbeams versus broad beam irradiation 
S. Bartzsch1, A. Merrem2, U. Oelfke1 
1The Institute of Cancer Research, Physics, Sutton, United 
Kingdom  
2Deutsches Krebsforschungszentrum, Physical Models, 
Heidelberg, Germany  
 
Purpose/Objective: Microbeam Radiation Therapy (MRT) is a 
still preclinical radiotherapy approach that uses synchrotron 
radiation to shape arrays of 25-100 µm wide planar beams 
separated by a few 100 µm. It places particular high hopes on 
the treatment of infantile, inoperable brain tumours. Several 
preclinical studies revealed an extremely high tolerance of 
normal tissue to these irradiation patterns while tumours 
were effectively controlled. Whereas several preclinical 
studies were able to impressively confirm the differential 
effect and the normal tissue sparing, a satisfying explanation 
does not yet exist. Apart from bystander effects the vessel 
system was identified to play an important role. 
Regeneration and repair originating in the tissue in the low 
dose regions could be responsible for a rapid recovery after 
treatment. By simulating irradiations of a computer modelled 
vascular system we investigate the possibility of a geometric 
explanation. 
Materials and Methods: We simulated a cerebral cortical 
vascular and capillary network fitting important observed 
physiological parameters such as the vessel radii. Based on 
observed cell survival curves a radiation response model was 
developed for vessels and capillaries. After a simulated 
irradiation with either microbeams or a seamless beam at the 
same mean dose the vascular length and the average cell-
vessel distance was assessed as a biological endpoint.  
Results: Although our model does not incorporate repair 
mechanisms or bystander effects spatially fractionated beam 
geometries show a clear tissue sparing effect compared to 
seamless irradiations (s. figure). This effect increases with an 
increasing peak to valley dose ratio (PVDR). We were able to 
attribute this effect to a convex dose-response relationship. 
Furthermore we were able to show that the vascular network 
morphology has a strong influence on the tissue damage after 
MRT exposure. Especially the distribution of vessel radii 
appears to be crucial. This may explain the differential effect 
on tumours and normal tissue. 
 
 
Conclusions: Even without taking into account repair 
mechanisms and bystander effects, a tissue sparing effect of 
MRT may be explained by a convex dose-response 
relationship. Assuming realistic treatment parameters an 
increase in the blood vessel surviving fraction by a factor of 3 
is supported in our simulations. More accurate experimental 
data on dose dependent cell survival and on tumour 
vasculature will help to enable a more quantitative and 
predictive analysis.  
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